(ASND) Ascendis Pharma AS - Performance 28.8% in 12m

ASND performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating 20.49%
#18 in Peer-Group
Rel. Strength 73.89%
#2011 in Stock-Universe
Total Return 12m 28.77%
#40 in Peer-Group
Total Return 5y 30.84%
#28 in Peer-Group
P/E Value
P/E Trailing -
P/E Forward -
High / Low USD
52 Week High 179.10 USD
52 Week Low 112.93 USD
Sentiment Value
VRO Trend Strength +-100 65.17
Buy/Sell Signal +-5 1.39
Support / Resistance Levels
Support
Resistance
12m Total Return: ASND (28.8%) vs XBI (-6.9%)
Total Return of Ascendis Pharma AS versus its related sector ETF XBI
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (ASND) Ascendis Pharma AS - Performance 28.8% in 12m

Top Performer in Biotechnology

Short Term Performance

Symbol 1w 1m 3m
ASND 1.51% 1.48% 27.5%
RGC 68.0% 3.32% 2,126%
PROK 650% 343% 645%
IPA 81.1% 187% 390%

Long Term Performance

Symbol 6m 12m 5y
ASND 36% 28.8% 30.8%
RGC 0.0% 0.0% 6,198%
DRUG -31.7% 2,493% -1.56%
ABVC 745% 514% -84.1%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
GILD NASDAQ
Gilead Sciences
0.92% 72.5% 80.4% 23.5 14.1 0.23 28.3% -3.71%
UTHR NASDAQ
United Therapeutics
-8.48% -6.85% 159% 11.3 10.5 1.43 74.6% 16.1%
AMGN NASDAQ
Amgen
2.26% -3.11% 38.6% 27.2 14.2 0.99 0.60% 41%
BIM PA
Biomerieux
-1.07% 32.1% -2.24% 32.7 25.8 1.55 -38.5% -25.1%
NBIX NASDAQ
Neurocrine Biosciences
6.19% -6.83% 5.89% 43 24.8 0.27 18.7% -34.3%
KMDA NASDAQ
Kamada
12.6% 39.2% -5% 27.6 22.4 0.9 68.9% 36.8%
PTCT NASDAQ
PTC Therapeutics
-5.71% 54.5% -7.69% 7.54 6.09 0.81 - 68%
ERF PA
Eurofins Scientific SE
1.98% 29.3% 17.2% 28.9 15.4 0.64 -62.1% -19.3%

Performance Comparison: ASND vs XBI vs S&P 500

XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ASND
Total Return (including Dividends) ASND XBI S&P 500
1 Month 1.48% 4.28% 4.37%
3 Months 27.47% 17.36% 14.09%
12 Months 28.77% -6.86% 13.68%
5 Years 30.84% -21.19% 112.88%

Trend Score (consistency of price movement) ASND XBI S&P 500
1 Month 15.3% 13.1% 83.6%
3 Months 75.6% 79.4% 97.2%
12 Months 68.9% -87.1% 45.7%
5 Years -7.2% -52.1% 84%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XBI vs. S&P 500
1 Month %th53.00 -2.69% -2.77%
3 Month %th58.00 8.62% 11.73%
12 Month %th80.50 38.25% 13.28%
5 Years %th86.50 66.03% -38.54%

FAQs

Does Ascendis Pharma AS (ASND) outperform the market?

Yes, over the last 12 months ASND made 28.77%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.86%. Over the last 3 months ASND made 27.47%, while XBI made 17.36%.

Performance Comparison ASND vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

ASND vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 0.9% -2.9% 27.9% 15%
US NASDAQ 100 QQQ 0.5% -3.5% 26.1% 16%
German DAX 40 DAX -1.7% -0.1% 15% -5%
Shanghai Shenzhen CSI 300 CSI 300 0.2% -2.1% 24.2% 9%
Hongkong Hang Seng HSI 2.4% -1.7% 7.4% -9%
India NIFTY 50 INDA 1.4% 0.7% 27.3% 30%
Brasil Bovespa EWZ 4.1% -2.4% 9.6% 25%

ASND vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 1.9% -2.3% 23.7% 5%
Consumer Discretionary XLY 2% -1.1% 36.4% 13%
Consumer Staples XLP 3.2% 1.7% 28.9% 21%
Energy XLE 0.2% -4.8% 34.8% 26%
Financial XLF 1.9% -1.6% 24.5% 1%
Health Care XLV 1.4% 0% 38.1% 34%
Industrial XLI 0.3% -2.4% 21.2% 3%
Materials XLB 1.1% -2.9% 24.7% 22%
Real Estate XLRE 2.4% 1.7% 28.7% 17%
Technology XLK -0.2% -6.3% 22.9% 18%
Utilities XLU 0.7% -0.8% 26.1% 6%
Aerospace & Defense XAR -0.2% -3.2% 9.3% -21%
Biotech XBI -2.1% -2.8% 37.8% 36%
Homebuilder XHB 0.3% -7.8% 33% 21%
Retail XRT 1.5% -0.6% 34% 18%

ASND vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -0.3% -5.29% 40.6% 32%
Natural Gas UNG 9.4% 15.7% 58.9% 39%
Gold GLD 2.7% 1.8% 12.9% -11%
Silver SLV 2.2% 2.7% 16.5% 11%
Copper CPER -4.9% -10.3% 8.5% 8%

ASND vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 2.3% -0.6% 32.1% 31%
iShares High Yield Corp. Bond HYG 1.7% -0.1% 30.9% 19%